BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi

Pediatric and Developmental Pathology

Volumn 18, Issue 1, 2015, Pages 1-9

  Salgado, Cláudia M ^a   Basu, Dipanjan ^a   Nikiforova, Marina ^b   Bauer, Bruce S ^c   Johnson, Donald ^c   Rundell, Veronica ^c   Grunwaldt, Lorelei J ^a   Reyes Múgica, Miguel ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

BRAF Mutation; Congenital melanocytic nevus; Neurocutaneous melanocytosis; NRAS mutation; Pediatric melanocytic proliferation

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; NRAS PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ASIAN; CAUCASIAN; CELL PROLIFERATION; CHILD; CLINICAL FEATURE; CODON; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; GIANT CONGENITAL MELANOCYTIC NEVUS; HUMAN; HYPERTRICHOSIS; INFANT; LARGE CONGENITAL MELANOCYTIC NEVUS; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOCYTOSIS; NEUROCUTANEOUS MELANOCYTOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE N RAS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCUTANEOUS NODULE; GENETICS; MELANOMA; METABOLISM; MUTATION; NEVUS, PIGMENTED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHAKOMATOSIS; PHENOTYPE; PRESCHOOL CHILD; SKIN NEOPLASMS; TREATMENT OUTCOME;

ADOLESCENT; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; GTP PHOSPHOHYDROLASES; HUMANS; INFANT; MALE; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MUTATION; NEUROCUTANEOUS SYNDROMES; NEVUS, PIGMENTED; PHENOTYPE; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84923267101     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/14-10-1566-OA.1     Document Type: Article

References (29)

1. Castilla EE, da Graca Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol 1981;104:307-315.
2. Alikhan A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocuta-neous melanosis. J Am Acad Dermatol 2012;67:495.e1-495.e17, quiz 512-514.
3. Krengel S, Hauschild A, Schafer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 2006;155: 1-8.
4. Marghoob AA, Schoenbach SP, Kopf AW, Orlow SJ, Nossa R, Bart RS. Large congenital melanocytic nevi and the risk for the development of malignant melanoma. A prospective study. Arch Dermatol 1996;132:170-175.
5. Ruiz-Maldonado R, Tamayo L, Laterza AM, Duran C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr 1992;120:906-911.
6. Reyes-Mugica M, Chou P, Byrd S, et al. Nevomelanocytic proliferations in the central nervous system of children. Cancer 1993;72:2277-2285.
7. Ramaswamy V, Delaney H, Haque S, Marghoob A, Khakoo Y. Spectrum of central nervous system abnormalities in neurocutane-ous melanocytosis. Dev Med Child Neurol 2012;54:563-568.
8. Tian AG, Foster KA, Jakacki RI, Reyes-Mugica M, Greene S. Neurocutaneous melanosis is associated with tethered spinal cord. Childs Nerv Syst 2015;31:115-121.
9. Papp T, Schipper H, Kumar K, Schiffmann D, Zimmermann R. Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. Melanoma Res 2005;15:401-407.
10. Phadke PA, Rakheja D, Le LP, et al. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohisto-chemical, and molecular analyses of 43 cases. Am J Surg Pathol 2011;35:656-669.
11. Wu D, Wang M, Wang X, et al. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population. Am J Dermatopathol 2011;33:341-344.
12. Charbel C, Fontaine RH, Malouf GG, Picard A, Kadlub N, El-Murr N, et al. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. J Invest Dermatol 2014;134: 1067-1074.
13. Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 2013;133:2229-2236.
14. Ross AL, Sanchez MI, Grichnik JM. Molecular nevogenesis. Dermatol Res Pract 2011;2011:463184.
15. Etchevers HC. Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi. J Invest Dermatol 2014;134:879-882.
16. Gerami P, Paller AS. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi. J Invest Dermatol 2013;133: 2127-2130.
17. Castellano E, Downward J. RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2011;2:261-274.
18. Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 2011;11:761-774.
19. Spiegel J, Cromm PM, Zimmermann G, Grossmann TN, Waldmann H. Small-molecule modulation of Ras signaling. Nat Chem Biol 2014;10:613-622.
20. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-724.
21. Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol 2013;68:441-451.
22. Kadonaga JN, Frieden IJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol 1991;24:747-755.
23. Bekiesinska-Figatowska M, Szczygielski O, Boczar M, et al. Neurocutaneous melanosis in children with giant congenital melanocytic nevi. Clin Imaging 2014;38:79-84.
24. Byrd SE, Reyes-Mugica M, Darling CF, Chou P, Tomita T. MR of leptomeningeal melanosis in children. Eur J Radiol 1995;20:93-99.
25. Ellison G, Donald E, McWalter G, et al. A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples. J Exp Clin Cancer Res 2010;29:132.
26. Munoz-Hidalgo L, Lopez-Gines C, Navarro L, et al. BRAF V600E mutation in two distinct meningeal melanocytomas associated with a nevus of Ota. J Clin Oncol 2014;32:e72-e75.
27. Schäfer N, Scheffler B, Stuplich M, et al. Vemurafenib for leptomeningeal melanomatosis. J Clin Oncol 2013;31:e173-e174.
28. Kinsler VA, Abu-Amero S, Budd P, et al. Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development. J Invest Dermatol 2012;132:2026-2032.
29. Marghoob AA, Dusza S, Oliveria S, Halpern AC. Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol 2004;140:171-175.